Corneal Toxicity in Patients Treated by BELANTAMAB MAFODOTIN: How to Improve and Facilitate Patients Follow-Up Using Refractive Shift?
Chauvier J, Trone MC, Gain P, Ollier E, Robert PY, Arnould L, Bourcier T, Cassagne M, Maalouf J, Martel A, Hoffart L, Rousseau A, Mathis T; French Belantamb Study Group,; Labetoulle M.
Chauvier J, et al. Among authors: maalouf j.
J Ocul Pharmacol Ther. 2024 Sep;40(7):410-418. doi: 10.1089/jop.2024.0023. Epub 2024 Jul 8.
J Ocul Pharmacol Ther. 2024.
PMID: 38976493